Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease
- PMID: 17712749
- DOI: 10.1086/520985
Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease
Abstract
Background: Chronic granulomatous disease (CGD) is associated with multiple and recurrent infections. In patients with CGD, invasive pulmonary infection with Aspergillus species remains the greatest cause of mortality and is typically insidious in onset. Acute fulminant presentations of fungal pneumonia are catastrophic.
Methods: Case records, radiograph findings, and microbiologic examination findings of patients with CGD who had acute presentations of dyspnea and diffuse pulmonary infiltrates caused by invasive fungal infection were reviewed and excerpted onto a standard format.
Results: From 1991 through 2004, 9 patients who either were known to have CGD or who received a subsequent diagnosis of CGD presented with fever and new onset dyspnea. Eight patients were hypoxic at presentation; bilateral pulmonary infiltrates were noted at presentation in 6 patients and developed within 2 days after initial symptoms in 2 patients. All patients received diagnoses of invasive filamentous fungi; 4 patients had specimens that also grew Streptomyces species on culture. All patients had been exposed to aerosolized mulch or organic material 1-10 days prior to the onset of symptoms. Cases did not occur in the winter. Five patients died. Two patients, 14 years of age and 23 years of age, who had no antecedent history of recognized immunodeficiency, were found to have p47(phox)-deficient CGD.
Conclusions: Acute fulminant invasive fungal pneumonia in the absence of exogenous immunosuppression is a medical emergency that is highly associated with CGD. Correct diagnosis has important implications for immediate therapy, genetic counseling, and subsequent prophylaxis.
Similar articles
-
Fulminant mulch pneumonitis in a previously healthy child.Arch Pediatr. 2018 Nov;25(8):495-496. doi: 10.1016/j.arcped.2018.09.003. Epub 2018 Oct 16. Arch Pediatr. 2018. PMID: 30340947
-
Chronic granulomatous disease presenting as fulminant Aspergillus pneumonitis: a lethal combination?Pediatr Crit Care Med. 2009 Jul;10(4):e43-5. doi: 10.1097/PCC.0b013e318198b22a. Pediatr Crit Care Med. 2009. PMID: 19584634
-
Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.J Allergy Clin Immunol. 2013 Nov;132(5):1156-1163.e5. doi: 10.1016/j.jaci.2013.05.039. Epub 2013 Jul 31. J Allergy Clin Immunol. 2013. PMID: 23910690
-
Advances in the diagnosis and treatment of chronic granulomatous disease.Curr Opin Hematol. 2011 Jan;18(1):36-41. doi: 10.1097/MOH.0b013e32834115e7. Curr Opin Hematol. 2011. PMID: 21076296 Review.
-
Seven chronic granulomatous disease cases in a single-center experience and a review of the literature.Asian Pac J Allergy Immunol. 2018 Mar;36(1):35-41. doi: 10.12932/AP0859. Asian Pac J Allergy Immunol. 2018. PMID: 28577521 Review.
Cited by
-
Pulmonary Aspergillosis in a Previously Healthy 13-Year-Old Boy.Can Respir J. 2016;2016:4575942. doi: 10.1155/2016/4575942. Epub 2016 Feb 25. Can Respir J. 2016. PMID: 27445540 Free PMC article.
-
Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease.Clin Infect Dis. 2011 Mar 15;52(6):e136-43. doi: 10.1093/cid/ciq250. Clin Infect Dis. 2011. PMID: 21367720 Free PMC article.
-
Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality.Cell Death Differ. 2011 Apr;18(4):581-8. doi: 10.1038/cdd.2011.1. Epub 2011 Feb 4. Cell Death Differ. 2011. PMID: 21293492 Free PMC article. Review.
-
Inflammation and repeated infections in CGD: two sides of a coin.Cell Mol Life Sci. 2012 Jan;69(1):7-15. doi: 10.1007/s00018-011-0834-z. Epub 2011 Nov 15. Cell Mol Life Sci. 2012. PMID: 22083605 Free PMC article. Review.
-
Invasive mucormycosis in chronic granulomatous disease.Saudi Med J. 2016 May;37(5):567-9. doi: 10.15537/smj.2016.5.14239. Saudi Med J. 2016. PMID: 27146621 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical